gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Elranatamab binds CD3 on T cells to activate and redirect them to kill BCMA-expressing plasma cells via perforin/granzyme-mediated cytolysis; CD3+ T cells are engaged, not killed.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
CD3 complex component on T cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06138275
disease_id_num_tar_ref
5930
drug_id_num_tar_ref
16071